Disease Models & Mechanisms (Jan 2014)

The myopathy-causing mutation DNM2-S619L leads to defective tubulation in vitro and in developing zebrafish

  • Elizabeth M. Gibbs,
  • Ann E. Davidson,
  • William R. Telfer,
  • Eva L. Feldman,
  • James J. Dowling

DOI
https://doi.org/10.1242/dmm.012286
Journal volume & issue
Vol. 7, no. 1
pp. 157 – 161

Abstract

Read online

DNM2 is a ubiquitously expressed GTPase that regulates multiple subcellular processes. Mutations in DNM2 are a common cause of centronuclear myopathy, a severe disorder characterized by altered skeletal muscle structure and function. The precise mechanisms underlying disease-associated DNM2 mutations are unresolved. We examined the common DNM2-S619L mutation using both in vitro and in vivo approaches. Expression of DNM2-S619L in zebrafish led to the accumulation of aberrant vesicular structures and to defective excitation-contraction coupling. Expression of DNM2-S619L in COS7 cells resulted in defective BIN1-dependent tubule formation. These data suggest that DNM2-S619L causes disease, in part, by interfering with membrane tubulation.

Keywords